About KINEA BIO INC
Kinea Bio is a biotechnology company founded in 2020 by respected scientific leaders in the neuromuscular disease space, focused on advancing next-generation genetic medicine through bench-to-bedside innovations.
Development of gene therapy for neuromuscular diseasesResearch in AAV-gene therapy outcomesPublication of scientific papers on genetic medicineNon-viral gene therapy delivery researchCollaboration with academic and research institutions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KINEA BIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.